October 7, 2025

HUTCHMED (HCM) Stock Analysis: Exploring a 39% Potential Upside Amidst a Competitive Landscape

HUTCHMED (China) Limited (NASDAQ: HCM), a Hong Kong-based biopharmaceutical company, stands out with its ambitious focus on discovering and commercializing innovative therapies for cancer and immunological diseases. With a market..

Harmony Biosciences (HRMY): A Promising Biotech with a 67% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has caught the attention of investors with its significant potential upside of 67.53%, according to analyst ratings. As a key player in the biotechnology..

Select Medical Holdings Corp (SEM): Analyst Ratings Signal 33% Upside Potential in Healthcare Sector

Select Medical Holdings Corporation (NYSE: SEM) stands as a significant player in the U.S. healthcare industry, specializing in critical illness recovery, rehabilitation hospitals, and outpatient rehabilitation clinics. With a current..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Biopharma Gem with 27.60% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a dynamic player in the biopharmaceutical landscape, is capturing the attention of investors with its promising pipeline and steady revenue growth. Based in the United..

NovoCure Limited (NVCR) Stock Analysis: A Closer Look at an 87.5% Potential Upside in the Medical Device Sector

NovoCure Limited (NVCR), a pioneering oncology company based in Baar, Switzerland, is making waves in the healthcare sector with its innovative tumor treating fields (TTFields) technology. Despite recent challenges, the..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Examining the 15.4% Potential Upside in Revolutionary Gene Editing

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the gene editing space, stands at a compelling intersection of biotechnology and groundbreaking medical solutions. With a focus on harnessing the..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a 36.26% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a key player in the healthcare sector specializing in medical devices, offers an intriguing proposition for investors navigating the complex diagnostics landscape. With its headquarters in..

Organon & Co. (OGN) Stock Analysis: Strong Upside Potential Amid Volatile Market Dynamics

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, specifically within the general drug manufacturing industry, offers an intriguing investment opportunity for those looking to navigate the..

LivaNova PLC (LIVN) Stock Analysis: Navigating a 23% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with a compelling 23.31% potential upside. Headquartered in London,..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 46.51% Potential Upside for Investors

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors. With a market capitalization of $3..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a 20% Upside Potential in the Biotech Sector

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is making waves in the biotechnology sector with a market capitalization of $5.18 billion and a current stock price of $37.50. As investors look for..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: An Ambitious Biotech with a 92.58% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a San Diego-based biotechnology company, has garnered significant attention in the investment community, thanks to its innovative approach to treating rare endocrine diseases and the..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Uncovering a 53.71% Potential Upside in Biotech

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands as a fascinating player in the biotechnology sector, with a market capitalization of $3.08 billion. Based in Waltham, Massachusetts, Apellis is carving its niche..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Is a 50% Upside on the Horizon?

For investors with an eye on the healthcare sector, LifeStance Health Group, Inc. (NASDAQ: LFST) presents a compelling opportunity, particularly given its significant potential upside of over 50% according to..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a Potential 185.92% Upside for Biotech Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out in the biotechnology sector with a market cap of $3.63 billion. Headquartered in the United States, the company is making waves with its..

Immunovant, Inc. (IMVT) Stock Analysis: Examining the 141% Potential Upside in Biotech Innovation

For investors with an appetite for risk and a keen interest in the biotechnology sector, Immunovant, Inc. (NASDAQ: IMVT) presents a compelling case with its significant upside potential. The company,..

Concentra Group Holdings Parent (CON) Stock Analysis: Strong Buy Ratings and 36% Potential Upside

Concentra Group Holdings Parent, Inc. (CON), a notable player in the healthcare sector, particularly within the medical care facilities industry, is drawing attention from individual investors. The company’s current market..

Sotera Health Company (SHC) Investor Outlook: Analyzing the Stock’s Resilience Amid Healthcare Sector Dynamics

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector’s diagnostics and research industry, offering a robust array of services that include sterilization, lab testing, and advisory solutions. With..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating the 55% Upside Potential

As investors navigate the ever-evolving landscape of healthcare stocks, Perrigo Company plc (NYSE: PRGO) emerges as a notable consideration. Operating within the Drug Manufacturers – Specialty & Generic industry, this..

The architecture powering Zero Trust at the edge

Device Authority is redefining Zero Trust for the connected edge, embedding automated trust anchors into every device from manufacturing to decommissioning...
Search

Funds

October 7, 2025

The architecture powering Zero Trust at the edge

Device Authority is redefining Zero Trust for the connected edge, embedding automated trust anchors into every device from manufacturing to decommissioning...
Search

Funds

October 7, 2025

FTSE 100

Funds